Home > Healthcare > Pharmaceuticals > Finished Drug Form > U.S. Medical Marijuana Market

U.S. Medical Marijuana Market Share

Report ID: GMI2890
Published Date: Oct 2022
Report Format: PDF

Download Free Sample

U.S. Medical Marijuana Market Share

Some of the leading companies in the U.S. medical marijuana market are:

Aurora Cannabis Inc
GW Pharmaceuticals
Cannabis Sativa Inc
Emerald Health Therapeutics Inc
The Cronos Group Inc
Tilray
Lexaria Bioscience Corp
Curaleaf
Green Roads
CHARLOTTE’S WEB
Canopy Growth Corporation
Gaia Herbs
Medical Marijuana
Folium Biosciences.

These companies are focusing on product commercialization and patents by means of collaboration with related firms.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. market for medical marijuana was valued at over USD 9 billion in 2021 and is projected to expand at more than 10% CAGR between the estimated timeframe of 2022-2030.

Pain management applications was over USD 7 billion in 2021 due to the rise in the number of patients with chronic and neuropathic pain in the U.S.

South Atlantic U.S. medical marijuana market size is anticipated to exceed USD 3 billion by 2030 owing to increasing efforts to boost the production of cannabis products.

Tilray, Curaleaf, Green Roads, CHARLOTTE’S WEB, Gaia Herbs, Medical Marijuana, and Folium Biosciences are some of the leading companies in the U.S. market.